James D. Moyer

5.5k citations

51 papers · 3.3k indexed · 1 hit paper · h-index 31

Impact in

Oncology top 5%
- HER2/EGFR in Cancer Research
Molecular Biology top 5%
- Biochemical and Molecular Research
- Heat shock proteins research

Papers in

Physiology 6
- Adenosine and Purinergic Signaling 5
Toxicology 3

Co-authors: Robert E. Handschumacher Nicholas M. Dean Bruce Wong Donald A. Wilson Russell O. Potts Rodney C. Schnur Deborah A. Baker Elsa G. Barbacci
Journals: Journal of Biological Chemistry (6 papers)Biochemical Journal (4 papers)Biochemical Pharmacology (4 papers)Biochemical and Biophysical Research Communications (4 papers)Journal of Medicinal Chemistry (3 papers)
Partner nations: United States Canada Malaysia

In The Last Decade

James D. Moyer

51 papers receiving 3.2k citations

Hit Papers

align trajectories log scale

Correlation Between Sweat Glucose and Blood Glucose in Subjects with Diabetes 2012 · 465 citations

Peers

Countries citing papers authored by James D. Moyer

Since Specialization

Citations

This map shows the geographic impact of James D. Moyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Moyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Moyer more than expected).

Fields of papers citing papers by James D. Moyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D. Moyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Moyer. The network helps show where James D. Moyer may publish in the future.

Co-authors

The 25 scholars most cited alongside James D. Moyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James D. Moyer Line = papers co-authored together James D. Moyer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Synthesis and biological evaluation of isoprenylated coumarins as potential anti-pancreatic cancer agents Bioorganic & Medicinal Chemistry Letters ·Maria Jun, Alyssa F. Bacay, James D. Moyer, Andrew C. Webb, Dora Carrico-Moniz	2014	31
2	Correlation Between Sweat Glucose and Blood Glucose in Subjects with Diabetes Diabetes Technology & Therapeutics ·James D. Moyer, Donald A. Wilson, Irina Finkelshtein, Bruce Wong, Russell O. Potts Hit paper breakdown →	2012	465
3	Discovery and Pharmacologic Characterization of CP-724,714, a Selective ErbB2 Tyrosine Kinase Inhibitor Cancer Research ·Jitesh P. Jani, Richard S. Finn, Mary E. Campbell, Kevin Coleman, Richard D. Connell, Nicolas Currier, Erling O. Emerson, Eugenia Floyd, Shawn Harriman, John C. Kath, Joel Morris, James D. Moyer, Leslie R. Pustilnik, Kristina Rafidi, Sherry L. Ralston, Ann Marie Rossi, Stefanus J. Steyn, Larry E. Wagner, Steven M. Winter, Samit K. Bhattacharya	2007	62
4	The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer Bioorganic & Medicinal Chemistry Letters ·Blaise Lippa, Goss S. Kauffman, Joel T. Arcari, Tricia A. Kwan, Jinshan Chen, William Hungerford, Samit K. Bhattacharya, Xumiao Zhao, Courtney Williams, Jun Xiao, Leslie R. Pustilnik, Chunyan Su, James D. Moyer, Ling Ma, Mary E. Campbell, Stefanus J. Steyn	2007	20
5	The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells. PubMed ·Elsa G. Barbacci, Leslie R. Pustilnik, Ann Marie Rossi, Erling O. Emerson, Penny E. Miller, Brian P. Boscoe, Eric Cox, Kenneth K. Iwata, Jitesh P. Jani, Kathleen Provoncha, John C. Kath, Zhengyu Liu, James D. Moyer	2003	40
6	Achieving selectivity between highly homologous tyrosine kinases: a novel selective erbB2 inhibitor Biochemical and Biophysical Research Communications ·Samit K. Bhattacharya, Eric Cox, John C. Kath, Alan M. Mathiowetz, Joel Morris, James D. Moyer, Leslie R. Pustilnik, Kris Rafidi, Daniel T. Richter, Chunyan Su, Matthew D. Wessel	2003	16
7	ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network Molecular and Cellular Biology ·Ronit Pinkas‐Kramarski, Maya Shelly, Bradley C. Guarino, Ling Mei Wang, Ljuba Lyass, Iris Alroy, Mauricio Alamandi, Angera H. Kuo, James D. Moyer, Sara Lavi, Miriam Eisenstein, Barry Ratzkin, Rony Seger, Sarah Bacus, Jacalyn H. Pierce, Glenn C. Andrews, Yosef Yarden	1998	113
8	p185erbB2 Binds to GRP94 in Vivo Journal of Biological Chemistry ·Christine Chavany, Edward G. Mimnaugh, Penny E. Miller, Roberto Bitton, Phongmai Nguyen, Jane B. Trepel, Luke Whitesell, Rodney C. Schnur, James D. Moyer, Len Neckers	1996	226
9	The Structural Basis for the Specificity of Epidermal Growth Factor and Heregulin Binding Journal of Biological Chemistry ·Elsa G. Barbacci, Bradley C. Guarino, Justin G. Stroh, David H. Singleton, Kenneth J. Rosnack, James D. Moyer, Glenn C. Andrews	1995	79
10	Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives Journal of Medicinal Chemistry ·Rodney C. Schnur, Michael L. Corman, Randall J. Gallaschun, Beth Cooper, Michael F. Dee, Jonathan L. Doty, M. L. Muzzi, James D. Moyer, C DiOrio	1995	162
11	Cyclopentenyl uracil: An effective inhibitor of uridine salvage in vivo Biochemical Pharmacology ·Richard L. Cysyk, Nancy Malinowski, Víctor E. Márquez, Daniel Zaharevitz, Elias August, James D. Moyer	1995	9
12	Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins. PubMed ·Penny E. Miller, C DiOrio, Mary Pat Moyer, Rodney C. Schnur, Arthur M. Bruskin, Walter Cullen, James D. Moyer	1994	98
13	Binding of Benzoquinoid Ansamycins to p100 Correlates with Their Ability to Deplete the erbB2 Gene Product p185 Biochemical and Biophysical Research Communications ·Penny E. Miller, Rodney C. Schnur, Elsa G. Barbacci, M. P. Moyer, James D. Moyer	1994	40
14	Modulation of bombesin-induced phosphatidylinositol hydrolysis in a small-cell lung-cancer cell line Biochemical Journal ·Jane B. Trepel, James D. Moyer, Reino Heikkilä, Edward A. Sausville	1988	38
15	A Correlation of Bombesin‐Responsiveness with Myc‐Family Gene Expression in Small Cell Lung Carcinoma Cell Lines Annals of the New York Academy of Sciences ·Edward A. Sausville, James D. Moyer, Reino Heikkilä, Len Neckers, Jane B. Trepel	1988	16
16	A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line Biochemical and Biophysical Research Communications ·Jane B. Trepel, James D. Moyer, Frank Cuttitta, Harold Frucht, David H. Coy, Ronald B. Natale, James L. Mulshine, Robert T. Jensen, E. A. Sausville	1988	58
17	Uptake and metabolism of myo-inositol by L1210 leukaemia cells Biochemical Journal ·James D. Moyer, Nancy Malinowski, Elizabeth Napier, John Strong	1988	15
18	Inhibition of uridine kinase and the salvage of uridine by modified pyrimidine nucleosides. Molecular Pharmacology ·James D. Moyer, Jean M. Karle, Nancy Malinowski, Víctor E. Márquez, M A Salam, Louis Malspeis, Richard L. Cysyk	1985	5
19	Effects of n-(phosphonacetyl)-l-aspartate (pala) on circulating pyrimidine nucleosides, nucleotide pools, and nucleic acid synthesis. Abstr. Research in Nursing & Health ·James D. Moyer, Patricia Smith, Robert E. Handschumacher	1980	1
20	Crystalline alpha and beta forms of 3-O-a-D-glucopyranosyl-D-arabinopyranose Journal of Research of the National Bureau of Standards Section A Physics and Chemistry ·Horace S. Isbell, H.L. Frush, James D. Moyer	1968	3

About James D. Moyer

James D. Moyer is a scholar working on Physiology, Toxicology, Molecular Biology, Oncology and Genetics, having authored 51 papers that have together received 3.3k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (16 papers), HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Adenosine and Purinergic Signaling (5 papers), HIV/AIDS drug development and treatment (5 papers), Phytase and its Applications (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Oncology (864 citations), Molecular Biology (2.0k citations), Physiology (115 citations), Bioengineering (105 citations) and Toxicology (54 citations). James D. Moyer has collaborated with scholars based in United States, Canada and Malaysia. Frequent co-authors include Robert E. Handschumacher, Nicholas M. Dean, Bruce Wong, Donald A. Wilson, Russell O. Potts, Rodney C. Schnur, Deborah A. Baker, Elsa G. Barbacci, Jane B. Trepel and Víctor E. Márquez. Their work appears in journals such as Journal of Biological Chemistry, Biochemical Journal, Biochemical Pharmacology, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact